Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polyps 1Neoplasms 1Adenoma 1

Interventions

Cyclophosphamide 222pembrolizumab 199Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 153Docetaxel 139Rituximab 137Bevacizumab 137Radiotherapy 136Dexamethasone 126Nivolumab 125Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 62Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Has results × Colonoscopy × Clear all
NCT02926209 2019-07-16

Post Market Evaluation of Aer-O-Scope Visualization

GI View Ltd.

Phase NA Terminated
104 enrolled 5 charts

Adenoma, Neoplasms, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡